
-
2014
Company Description
ODIN Biotech Partners, LLC is a development-stage biotechnology company focused on developing novel peptide therapeutics
ODIN Biotech Partners, LLC is a development-stage biotechnology company focused on developing novel peptide therapeutics for diseases of the retina. ODIN’s lead product, C16Y, is currently in preclinical development for the treatment of wet age-related macular degeneration (AMD). ODIN expects to begin clinical studies of C16Y in early 2016.
-
Manufacturer:
Science and Engineering -
Formed:
2014 -
Company Website:
-
Company E-mail:
-
Company Address:
3401 Armstrong Ave.Dallas, TXUnited States -
CEO:
- Karl Csaky
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits